Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 12 January 2026Published: 23 June 2015
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal) (TA750)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 December 2021
Pancreatic cancer in adults: diagnosis and management (NG85)Product type:GuidanceProgramme:NICE guidelinePublished: 7 February 2018
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer (TA476)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 6 September 2017
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine (TA440)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 April 2017